Georgia's Online Cancer Information Center

Find A Clinical Trial

Fiber-Rich Foods for the Treatment of Obesity and Prevention of Colon Cancer

Status
Active
Cancer Type
Colon/Rectal Cancer
Trial Phase
Phase II
Eligibility
40 - 75 Years, Male and Female
Study Type
Prevention
NCT ID
NCT04780477
Protocol IDs
RSPH5056-20 (primary)
NCI-2020-04372
Study Sponsor
Emory University Hospital/Winship Cancer Institute

Summary

This phase II trial investigates whether a high-fiber diet featuring legumes can reduce obesity and colon cancer risk in middle-aged overweight and obese participants that may have undergone removal of a polyp (polypectomy). A natural high-fiber diet based on legumes may lead to greater weight loss and improvements in biomarkers associated with colon cancer risk compared to a control diet.

Objectives

PRIMARY OBJECTIVE:
I. To test whether a high-fiber diet based on legumes, such as dry beans, can lead to sustained reductions in obesity and colon cancer risk in those at highest risk, namely overweight / obese post-polypectomy patients.

OUTLINE: Participants are randomized to 1 of 2 groups.

GROUP I (HIGH-FIBER DIET): Participants receive a high-fiber diet consisting of pre-portioned single-serving entree meals with legumes twice daily (BID) for months 1-3, and once daily (QD) for months 4-6. Participants continue on their respective diets for months 7-12. Participants are contacted by the study coordinator regularly during the first 1-2 weeks to answer their questions, provide support, and encourage adherence.

GROUP II (CONTROL DIET): Participants receive a healthy American diet consisting of pre-portioned single-serving meal replacement entrees with lean chicken/meat BID for months 1-3, and QD for months 4-6. Participants continue on their respective diets for months 7-12. Participants are contacted by the study coordinator regularly during the first 1-2 weeks to answer their questions, provide support, and encourage adherence.

After completion of study, participants are followed up for 1 year, and then until the next routine surveillance colonoscopy for those who have a colonoscopy.

Eligibility

  1. Free-living adults 40-75 years (yrs.) old
  2. Body mass index (BMI) 25-40 kg/m^2
  3. Colonoscopy within 3 years that found >= 1 adenoma >= 0.5 cm
  4. English speaking
  5. Ambulatory, able to pick up food, participate in clinical exams and laboratory tests
  6. Able to provide informed consent

Treatment Sites in Georgia

Winship Cancer Institute of Emory University


1365 Clifton Road NE
Building C
Atlanta, GA 30322
404-778-5180
winshipcancer.emory.edu

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.